EP1868601A4 - Mitotische kinesin-hemmer - Google Patents

Mitotische kinesin-hemmer

Info

Publication number: EP1868601A4
Authority: EP; European Patent Office
Prior art keywords: inhibitors; mitotic kinesin; kinesin; mitotic
Prior art date: 2005-04-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP06749225A

Other languages

English (en)

French (fr)

Other versions

EP1868601A1 (de

Inventor

Paul J Coleman

Christopher D Cox

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Sharp & Dohme LLC

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-07

Filing date

2006-04-03

Publication date

2008-12-10

2006-04-03 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

2007-12-26 Publication of EP1868601A1 publication Critical patent/EP1868601A1/de

2008-12-10 Publication of EP1868601A4 publication Critical patent/EP1868601A4/de

Status Withdrawn legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP06749225A 2005-04-07 2006-04-03 Mitotische kinesin-hemmer Withdrawn EP1868601A4 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US66908505P	2005-04-07	2005-04-07
PCT/US2006/012462 WO2006110390A1 (en)	2005-04-07	2006-04-03	Mitotic kinesin inhibitors

Publications (2)

Publication Number	Publication Date
EP1868601A1 EP1868601A1 (de)	2007-12-26
EP1868601A4 true EP1868601A4 (de)	2008-12-10

Family

ID=37087336

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP06749225A Withdrawn EP1868601A4 (de)	2005-04-07	2006-04-03	Mitotische kinesin-hemmer

Country Status (7)

Country	Link
US (1)	US7629373B2 (de)
EP (1)	EP1868601A4 (de)
JP (1)	JP2008535839A (de)
CN (1)	CN101155583B (de)
AU (1)	AU2006235022B2 (de)
CA (1)	CA2602146A1 (de)
WO (1)	WO2006110390A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005319455A1 (en) *	2004-12-21	2006-06-29	Merck Sharp & Dohme Corp.	Mitotic kinesin inhibitors
MX2009007395A (es) *	2007-01-09	2009-07-17	Bayer Schering Pharma Ag	Marcacion radioactiva por fluoracion de aziridinas.
WO2009052288A1 (en)	2007-10-19	2009-04-23	Schering Corporation	Spiro-condensed 1, 3, 4-thiadiazole derivatives for inhibiting ksp kinesin activity
CA2702990A1 (en) *	2007-11-09	2009-05-14	Schering Corporation	Compounds for inhibiting ksp kinesin activity
EP2558450A1 (de) *	2010-04-15	2013-02-20	Novartis AG	Triazolverbindungen als ksp-hemmer
WO2011128388A2 (en) *	2010-04-15	2011-10-20	Novartis Ag	Oxazole and thiazole compounds as ksp inhibitors
WO2012160447A1 (en) *	2011-05-25	2012-11-29	Dynamix Pharmaceuticals Ltd.	3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
AR111295A1 (es)	2017-03-20	2019-06-26	Forma Therapeutics Inc	Composiciones de pirrolopirrol como activadores de piruvato quinasa (pkr)
US20200129485A1 (en)	2018-09-19	2020-04-30	Forma Therapeutics, Inc.	Treating sickle cell disease with a pyruvate kinase r activating compound
WO2020061255A1 (en)	2018-09-19	2020-03-26	Forma Therapeutics, Inc.	Activating pyruvate kinase r
MX2022003025A (es)	2019-09-19	2022-04-07	Forma Therapeutics Inc	Activacion de la piruvato cinasa r.
US12128035B2 (en)	2021-03-19	2024-10-29	Novo Nordisk Health Care Ag	Activating pyruvate kinase R
KR20260019479A (ko)	2023-05-04	2026-02-10	레볼루션 메디슨즈, 인크.	Ras 관련 질환 또는 장애를 위한 병용 요법
CN121889155A (zh)	2023-08-07	2026-04-17	锐新医药公司	用于治疗ras蛋白相关疾病或病症的rmc-6291
AU2024360465A1 (en)	2023-10-12	2026-04-09	Revolution Medicines, Inc.	Macrocyclic ras inhibitors
WO2025171296A1 (en)	2024-02-09	2025-08-14	Revolution Medicines, Inc.	Ras inhibitors
WO2025240847A1 (en)	2024-05-17	2025-11-20	Revolution Medicines, Inc.	Ras inhibitors
US20250375445A1 (en)	2024-06-07	2025-12-11	Revolution Medicines, Inc.	Methods of treating a ras protein-related disease or disorder
WO2025265060A1 (en)	2024-06-21	2025-12-26	Revolution Medicines, Inc.	Therapeutic compositions and methods for managing treatment-related effects
WO2026006747A1 (en)	2024-06-28	2026-01-02	Revolution Medicines, Inc.	Ras inhibitors
WO2026015790A1 (en)	2024-07-12	2026-01-15	Revolution Medicines, Inc.	Methods of treating a ras related disease or disorder
WO2026015796A1 (en)	2024-07-12	2026-01-15	Revolution Medicines, Inc.	Methods of treating a ras related disease or disorder
WO2026015801A1 (en)	2024-07-12	2026-01-15	Revolution Medicines, Inc.	Methods of treating a ras related disease or disorder
WO2026015825A1 (en)	2024-07-12	2026-01-15	Revolution Medicines, Inc.	Use of ras inhibitor for treating pancreatic cancer
WO2026050446A1 (en)	2024-08-29	2026-03-05	Revolution Medicines, Inc.	Ras inhibitors
WO2026072904A2 (en)	2024-09-26	2026-04-02	Revolution Medicines, Inc.	Compositions and methods for treating lung cancer
WO2026090116A2 (en)	2024-10-21	2026-04-30	Revolution Medicines, Inc.	Ras inhibitors
US20260108528A1 (en)	2024-10-22	2026-04-23	Revolution Medicines, Inc.	Methods of treating a ras protein-related disease or disorder
WO2026090245A1 (en)	2024-10-22	2026-04-30	Revolution Medicines, Inc.	Use of ras inhibitors for treating cancer
WO2026106912A1 (en)	2024-11-12	2026-05-21	Revolution Medicines, Inc.	Ras inhibitors
WO2026112260A1 (en)	2024-11-21	2026-05-28	Revolution Medicines, Inc.	Ras inhibitors
WO2026122764A2 (en)	2024-12-06	2026-06-11	Revolution Medicines, Inc.	Ras inhibitors
WO2026128688A2 (en)	2024-12-13	2026-06-18	Revolution Medicines, Inc.	Ras inhibitors
WO2026161839A1 (en)	2025-01-27	2026-07-30	Revolution Medicines, Inc.	Ras inhibitors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003079973A2 (en) *	2002-03-08	2003-10-02	Merck & Co., Inc.	Mitotic kinesin inhibitors
WO2006007496A2 (en) *	2004-07-01	2006-01-19	Merck & Co., Inc.	Mitotic kinesin inhibitors
WO2006101761A2 (en) *	2005-03-16	2006-09-28	Merck & Co., Inc.	Mitotic kinesin inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PH27357A (en) *	1989-09-22	1993-06-21	Fujisawa Pharmaceutical Co	Pyrazole derivatives and pharmaceutical compositions comprising the same
US20020156104A1 (en)	1997-06-13	2002-10-24	Jerry L. Adams	Novel pyrazole and pyrazoline substituted compounds

2006
- 2006-04-03 EP EP06749225A patent/EP1868601A4/de not_active Withdrawn
- 2006-04-03 CN CN2006800113906A patent/CN101155583B/zh not_active Expired - Fee Related
- 2006-04-03 US US11/887,800 patent/US7629373B2/en not_active Expired - Fee Related
- 2006-04-03 JP JP2008505444A patent/JP2008535839A/ja not_active Withdrawn
- 2006-04-03 WO PCT/US2006/012462 patent/WO2006110390A1/en not_active Ceased
- 2006-04-03 AU AU2006235022A patent/AU2006235022B2/en not_active Expired - Fee Related
- 2006-04-03 CA CA002602146A patent/CA2602146A1/en not_active Abandoned

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003079973A2 (en) *	2002-03-08	2003-10-02	Merck & Co., Inc.	Mitotic kinesin inhibitors
WO2006007496A2 (en) *	2004-07-01	2006-01-19	Merck & Co., Inc.	Mitotic kinesin inhibitors
WO2006101761A2 (en) *	2005-03-16	2006-09-28	Merck & Co., Inc.	Mitotic kinesin inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2006110390A1 *

Also Published As

Publication number	Publication date
CN101155583B (zh)	2011-01-19
JP2008535839A (ja)	2008-09-04
CN101155583A (zh)	2008-04-02
WO2006110390A1 (en)	2006-10-19
US20090042966A1 (en)	2009-02-12
AU2006235022A1 (en)	2006-10-19
AU2006235022B2 (en)	2011-07-21
US7629373B2 (en)	2009-12-08
EP1868601A1 (de)	2007-12-26
CA2602146A1 (en)	2006-10-19

Legal Events

Date	Code	Title	Description
2007-11-23	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-12-26	17P	Request for examination filed	Effective date: 20071107
2007-12-26	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2008-07-16	DAX	Request for extension of the european patent (deleted)
2008-12-10	A4	Supplementary search report drawn up and despatched	Effective date: 20081110
2008-12-10	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/415 20060101AFI20061110BHEP Ipc: A61P 35/00 20060101ALI20081104BHEP Ipc: C07D 231/06 20060101ALI20081104BHEP
2009-03-04	17Q	First examination report despatched	Effective date: 20090202
2010-03-10	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: MERCK SHARP & DOHME CORP.
2012-08-08	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SCHERING CORPORATION
2012-08-15	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: MERCK SHARP & DOHME CORP.
2014-03-14	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2014-04-16	18D	Application deemed to be withdrawn	Effective date: 20131116

Publication	Publication Date	Title
EP1856128A4 (de)	2009-12-23	Inhibitoren von mitotischem kinesin
EP1656133A4 (de)	2008-10-29	Inhibitoren von mitotischem kinesin
DK1940839T3 (da)	2013-10-14	Pyridopyrimidione Inhibitors of P13Ka
EP1656146A4 (de)	2009-04-15	Inhibitoren von mitotischem kinesin
EP1656140A4 (de)	2009-03-04	Inhibitoren von mitotischem kinesin
EP1697331A4 (de)	2010-08-04	Inhibitoren von mitotischem kinesin
EP2083864A4 (de)	2010-12-08	Antagonisten von pcsk9
EP2083859A4 (de)	2010-11-24	Pcsk9-antagonisten
EP2083860A4 (de)	2010-05-26	Pcsk9-antagonisten
DK2848610T3 (da)	2017-11-06	Hæmmere af kinaseaktivitet
CY2013042I1 (el)	2015-12-09	Αναστολεις πυριδυλιου της σηματοδοτησης hedgehog
DK1898903T3 (da)	2013-07-01	Inhibitorer af Akt-aktivitet
CY2014012I1 (el)	2015-12-09	Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
CR10831A (es)	2009-06-18	INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA
DK2041138T3 (da)	2014-08-11	Pyrroltriazinkinase-inhibitorer
ZA200802585B (en)	2009-02-25	Pyridopyrimidinone inhibitors of Pl3Kα
DK2024375T3 (da)	2011-06-27	Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere
EP1704145A4 (de)	2009-08-05	Selektive kinaseinhibitoren
DOP2007000084A (es)	2007-12-31	Derivados de dihidropirazolopirimidinona
CR10562A (es)	2009-03-20	Nuevos derivados de piridazina
DK1916890T3 (da)	2017-01-02	Forbedrede egenskaber for græsendofytter
CR10809A (es)	2009-06-25	Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
EP2032141A4 (de)	2009-12-30	Januskinase-hemmer
EP1696927A4 (de)	2007-10-31	Inhibitoren von mitotischem kinesin
DK2066662T3 (da)	2013-01-07	Serinhydrolaseinhibitorer